Merrion Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $557K | Hold |
1,250
| – | – | 0.36% | 56 |
|
|
2025
Q1 | $606K | Buy |
1,250
+245
| +24% | +$119K | 0.44% | 54 |
|
|
2024
Q4 | $405K | Hold |
1,005
| – | – | 0.28% | 71 |
|
|
2024
Q3 | $467K | Hold |
1,005
| – | – | 0.31% | 67 |
|
|
2024
Q2 | $471K | Buy |
1,005
+5
| +0.5% | +$2.34K | 0.32% | 59 |
|
|
2024
Q1 | $418K | Hold |
1,000
| – | – | 0.3% | 65 |
|
|
2023
Q4 | $407K | Buy |
+1,000
| New | +$407K | 0.32% | 63 |
|